586 related articles for article (PubMed ID: 6978327)
21. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
22. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
Warlow R; Carrano J; Dawkins R
Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
[TBL] [Abstract][Full Text] [Related]
23. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
28. [Antibodies to soluble nuclear antigens in connective tissue diseases].
Rivero S; Jacobelli S
Rev Med Chil; 1982 May; 110(5):433-8. PubMed ID: 6984534
[No Abstract] [Full Text] [Related]
29. Case control study of antibodies to ENA in progressive systemic sclerosis patients.
Furst DE; Obrodovic M; Barnett EV; Clements PJ; Paulus HE
J Rheumatol; 1984 Jun; 11(3):298-305. PubMed ID: 6610753
[TBL] [Abstract][Full Text] [Related]
30. Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.
Okarma TB; Krueger JA; Holman HR
J Clin Invest; 1982 Aug; 70(2):296-303. PubMed ID: 6808026
[TBL] [Abstract][Full Text] [Related]
31. [Renal histology in 44 patients with specific antibodies of soluble nuclear antigens].
Meyer O; Gaudreau A; Peltier AP
Rev Rhum Mal Osteoartic; 1980 Oct; 47(10):561-8. PubMed ID: 6970963
[TBL] [Abstract][Full Text] [Related]
32. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
Peltier AP
Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
[No Abstract] [Full Text] [Related]
33. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
[TBL] [Abstract][Full Text] [Related]
35. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
[TBL] [Abstract][Full Text] [Related]
36. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
[TBL] [Abstract][Full Text] [Related]
37. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
38. Antibody profiles of sera giving different nuclear staining patterns.
Wangel AG; Teppo AM; Pollard A; Howarth S
Scand J Rheumatol; 1984; 13(4):303-9. PubMed ID: 6395320
[TBL] [Abstract][Full Text] [Related]
39. [Evidence of a new soluble nuclear antigen in mixed connective tissue disease with dysimmune lymphadenopathy and Sjögren syndrome without anti-ribonucleoprotein antibodies (RNP)].
Chestier Y; Roucayrol AM; Lee ML; Meyer O; Wyart P; Dumant D
Rev Med Interne; 1981; 2(4):425-9. PubMed ID: 6979078
[No Abstract] [Full Text] [Related]
40. Antibodies to native DNA in connective tissue disease. A comparison of radioimmunoassay, counterimmunoelectrophoresis and indirect immunofluorescence on Crithidia luciliae substrate.
Hodinka L; Merétey K; Jancsó A; Falus A; Korda J; Bozsóky S
Arch Immunol Ther Exp (Warsz); 1979; 27(5):641-6. PubMed ID: 398205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
